A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of JNJ-28431754 on Cardiovascular Outcomes in Adult Subjects With Type 2 Diabetes Mellitus
Phase of Trial: Phase III
Latest Information Update: 18 Aug 2017
At a glance
- Drugs Canagliflozin (Primary)
- Indications Cardiovascular disorders; Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms CANVAS
- Sponsors Janssen Research & Development
- 13 Jun 2017 Integrated results from the CANVAS trials published in a Janssen Cilag media release.
- 12 Jun 2017 Integrated results from the CANVAS program have been presented at the American Diabetes Association 77th Scientific Sessions according to a Janssen media release.
- 12 Jun 2017 Integrated results from the CANVAS trials published in a Janssen media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History